Foresite Capital, whose chief executive officer and managing director, Jim Tananbaum, has now been named to Forbes Midas List of Top Technology Investors making this the third year in a row. This list recognizes, each year, the top 100 venture capitalists that invest big in the newest future technology companies. This early investing strategy usually evolves into creating and exceptional value for the investors. This year Jim Tananbaum ranks #52 on the Midas List. More details can be found on Insidermonkey.
Foresite Capital, located in San Francisco with offices in New York. They help with the growth of emerging healthcare leaders by providing the needed capital. They work with these healthcare companies that serve all healthcare sectors in the public and private markets.
Dr. Jim Tananbaum wants to create several healthcare franchises across the country, to help identify financial and operational opportunities and create an investment strategy.
Foresite Capital has assets amounting to $1.1billion under management. They have invested recently in Nanostring Technologies Inc. This company has developed a system that will provide a wide range of new tools for use in basic research, Vitro diagnostic applications and translational medicine. It will also cover not only the researcher and the research, but medical labs electronic technicians and other specialist medicines.
Jim Tananbaum is an entrepreneur with over 25-years’ experience in healthcare and investing. His focus is on operational and financial opportunities with which to build the healthcare businesses. He has in this 25 years either founded or helped the healthcare franchises to grow in all aspects of healthcare economy.
While at Harvard, he co-founded GelTex Pharmaceuticals, that venture sold for $1.6 billion. He has also co-founded Prospect Venture II and III along with Theravance, Inc.
His making the Midas List for the third year in a row has been attributed to several investments of major proportions, which included Juno Therapeutics and a diabetes treatment unicorn, Intarcia Therapeutics. You can visit his Researchgate profile for more details.
Jim Tananbaum attended Yale University and earned a Bachelor of Arts/ Science degree, a Medical Doctor degree. Harvard University, and an MBA from Harvard Business School. He also holds a Master of Science degree from the Massachusetts Institute of Technology. You can search him on Google.